Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2007

View Archived Issues

Valeant's Xyrem launched in Canada for narcoleptics with cataplexy

Lilly receives approval in Japan for Cialis for erectile dysfunction

Paget's disease indication submitted for risedronate sodium hydrate as orphan drug

Cognitive data reported from EPOLYM trial of epoetin alfa

Genentech completes acquisition of Tanox

Gruenenthal claims new analgesic drugs in recent patent literature

Recent patents claim new compounds for the treatment of infectious diseases

New treatment options for psychological disorders described in recent patents

CeNeS grants rights to Ono for new intravenous anesthetic in Japan

Deforolimus new nonproprietary name for Ariad's AP-23573

TURNS network evaluating two different treatments for cognitive impairment in schizophrenia

Kosan enrolls patients in phase II/III trial of Hsp90 inhibitor tanespimycin

Depot formulation of olanzapine provides therapeutic D2 receptor occupancy

Promising results from phase II study of Iomai's patch-based ETEC E. coli vaccine

Phase III studies show Vidaza significantly increases survival in MDS

Novel inhibitors of HIV-1 protease dimerization described

ImmunoGen begins phase II trial of huC242-DM4 for gastric cancer

Regeneron and Bayer begin phase III study of VEGF Trap-Eye for wet AMD

PF-04548043 enters phase I for GERD

Array to initiate phase I trial of ErbB-2 inhibitor ARRY-380 for cancer

Phase II trial of Antisoma's AS-1411 in AML begins

Hana Biosciences begins phase II trial of Marqibo for ALL

Innovive reaches SPA agreement with FDA for pivotal phase II trial of tamibarotene

First approval for Pfizer's novel HIV treatment

NVA-237 progressing through clinical trials for COPD

North American clinical evaluation of GSK prepandemic H5N1 vaccine commences

FDA will review sBLA for Orencia in juvenile arthritis

Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...